+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9n4k | ||||||
|---|---|---|---|---|---|---|---|
| Title | CryoEM structure of ALK2-ActRIIB bound to BMP6 | ||||||
Components |
| ||||||
Keywords | SIGNALING PROTEIN / TGFB / Signaling / Receptor / Bone Morphogenetic Protein / ALK2 / Ligand / Growth Factor | ||||||
| Function / homology | Function and homology informationpositive regulation of aldosterone biosynthetic process / positive regulation of aldosterone secretion / Regulation of signaling by NODAL / activin receptor activity / activin receptor activity, type II / lymphatic endothelial cell differentiation / positive regulation of activin receptor signaling pathway / negative regulation of adherens junction organization / retina vasculature development in camera-type eye / endocardial cushion cell fate commitment ...positive regulation of aldosterone biosynthetic process / positive regulation of aldosterone secretion / Regulation of signaling by NODAL / activin receptor activity / activin receptor activity, type II / lymphatic endothelial cell differentiation / positive regulation of activin receptor signaling pathway / negative regulation of adherens junction organization / retina vasculature development in camera-type eye / endocardial cushion cell fate commitment / venous blood vessel development / acute inflammatory response / lymphangiogenesis / trophoblast cell migration / mitral valve morphogenesis / BMP receptor complex / BMP receptor activity / endocardial cushion fusion / positive regulation of chondrocyte differentiation / embryonic foregut morphogenesis / cardiac muscle cell fate commitment / atrial septum primum morphogenesis / type B pancreatic cell development / positive regulation of cardiac epithelial to mesenchymal transition / positive regulation of endothelial cell differentiation / artery development / positive regulation of determination of dorsal identity / transforming growth factor beta receptor activity, type I / eye development / smooth muscle cell differentiation / activin receptor activity, type I / activin receptor complex / negative regulation of adipose tissue development / pattern specification process / male genitalia development / BMP receptor binding / pharyngeal system development / endocardial cushion formation / receptor protein serine/threonine kinase / endochondral ossification / activin binding / cellular response to BMP stimulus / transmembrane receptor protein serine/threonine kinase activity / organ growth / Signaling by BMP / negative regulation of cell-cell adhesion mediated by cadherin / Signaling by Activin / activin receptor signaling pathway / negative regulation of activin receptor signaling pathway / anterior/posterior pattern specification / positive regulation of vascular permeability / gastrulation with mouth forming second / pancreas development / Signaling by NODAL / embryonic heart tube morphogenesis / dorsal/ventral pattern formation / positive regulation of lipopolysaccharide-mediated signaling pathway / transforming growth factor beta binding / determination of left/right symmetry / negative regulation of ossification / cartilage development / skeletal system morphogenesis / atrioventricular valve morphogenesis / kinase activator activity / negative regulation of cold-induced thermogenesis / insulin secretion / neural crest cell migration / cell surface receptor protein serine/threonine kinase signaling pathway / branching involved in blood vessel morphogenesis / odontogenesis of dentin-containing tooth / roof of mouth development / ventricular septum morphogenesis / negative regulation of G1/S transition of mitotic cell cycle / growth factor binding / SMAD binding / germ cell development / mesoderm development / mesoderm formation / peptide hormone binding / positive regulation of SMAD protein signal transduction / positive regulation of intracellular signal transduction / regulation of ossification / positive regulation of osteoblast differentiation / BMP signaling pathway / response to magnesium ion / response to retinoic acid / blood vessel remodeling / negative regulation of signal transduction / positive regulation of bone mineralization / response to glucose / positive regulation of endothelial cell proliferation / lung development / protein serine/threonine/tyrosine kinase activity / positive regulation of neuron differentiation / transforming growth factor beta receptor signaling pathway / post-embryonic development / positive regulation of epithelial cell proliferation / response to glucocorticoid / protein tyrosine kinase binding / cytokine activity Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.2 Å | ||||||
Authors | Goebel, E.J. / Saotome, K. / Franklin, M.C. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2025Title: CryoEM structure of ALK2:BMP6 reveals distinct mechanism that allow ALK2 to interact with both BMP and activin ligands. Authors: Erich J Goebel / Senem Aykul / Warren W Hom / Kei Saotome / Aris N Economides / Matthew C Franklin / Vincent J Idone / ![]() Abstract: Ligands in the transforming growth factor β (TGF-β) family [activins, Bone Morphogenetic Proteins (BMPs), and TGF-βs] signal by bringing together two type I and two type II receptors. Activin ...Ligands in the transforming growth factor β (TGF-β) family [activins, Bone Morphogenetic Proteins (BMPs), and TGF-βs] signal by bringing together two type I and two type II receptors. Activin receptor-like kinase-2 (ALK2) is the only type I receptor among the seven TGF-β type I receptors that interacts with both activin and BMP ligands. With BMPs, ALK2 acts as a signaling receptor to activate small mothers against decapentaplegic 1 (SMAD1)/5/8 signaling. Alternatively, with activins, such as Activin A (ActA), ALK2 forms nonsignaling complexes that negatively regulate ALK2 and ActA signaling. To gain insight into how ALK2 interacts with two distinct classes of ligands, we resolved the cryoelectron microscopy structure of ALK2 in complex with the type II receptor, ActRIIB, and the ligand, BMP6, in parallel with the corresponding structure with ALK3 for direct comparison. These structures demonstrate that ALK2 and ALK3 utilize different mechanisms to interact with BMP6 at the wrist interface, with ALK2 relying on BMP6 glycosylation and ALK3 relying on a salt bridge. Modeling of ALK2:ActA reveals that binding relies on ActA's fingertip region, mirroring the interaction of ActA with its other receptor, ALK4. Our results demonstrate that ALK2 is a "hybrid" receptor that incorporates features of BMP type I receptors such as ALK3 at the wrist interface and an activin type I receptor such as ALK4 at the fingertip. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9n4k.cif.gz | 130.1 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9n4k.ent.gz | 98.3 KB | Display | PDB format |
| PDBx/mmJSON format | 9n4k.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/n4/9n4k ftp://data.pdbj.org/pub/pdb/validation_reports/n4/9n4k | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 48883MC ![]() 9mirC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Activin receptor type- ... , 2 types, 4 molecules AFCD
| #1: Protein | Mass: 14933.380 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: ACVR2B / Production host: ![]() References: UniProt: Q13705, receptor protein serine/threonine kinase #3: Protein | Mass: 13189.880 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: ACVR1, ACVRLK2 / Production host: ![]() References: UniProt: Q04771, receptor protein serine/threonine kinase |
|---|
-Protein , 1 types, 2 molecules BE
| #2: Protein | Mass: 15695.711 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: BMP6, VGR / Production host: ![]() |
|---|
-Sugars , 3 types, 10 molecules 


| #4: Polysaccharide | | #5: Sugar | ChemComp-NAG / #6: Sugar | |
|---|
-Details
| Has ligand of interest | N |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Ternary complex of ALK2-ActRIIB with BMP6 / Type: COMPLEX / Details: ALK2-ActRIIB fused by Antibody Hinge region / Entity ID: #1-#3 / Source: RECOMBINANT | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Value: 0.08 MDa / Experimental value: NO | |||||||||||||||
| Source (natural) | Organism: Homo sapiens (human) | |||||||||||||||
| Source (recombinant) | Organism: ![]() | |||||||||||||||
| Buffer solution | pH: 7.5 / Details: 50mM Tris-HCL, 100mM NaCl | |||||||||||||||
| Buffer component |
| |||||||||||||||
| Specimen | Conc.: 3 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: Sample was mono disperse following purification over size exclusion chromatography. | |||||||||||||||
| Specimen support | Grid material: GOLD | |||||||||||||||
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: OTHER |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 105000 X / Nominal defocus max: 2400 nm / Nominal defocus min: 800 nm / Alignment procedure: BASIC |
| Specimen holder | Cryogen: NITROGEN / Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
| Image recording | Electron dose: 40 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) |
-
Processing
| EM software | Name: PHENIX / Version: 1.21.2_5419 / Category: model refinement | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| Symmetry | Point symmetry: C2 (2 fold cyclic) | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.2 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 42185 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | Protocol: RIGID BODY FIT / Space: REAL Details: Initial fitting was performed in ChimeraX and real-space refinement was carried out within Phenix. | ||||||||||||||||||||||||
| Atomic model building | 3D fitting-ID: 1 / Source name: PDB / Type: experimental model
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
United States, 1items
Citation


PDBj




surface plasmon resonance




